Compare Stocks: CLPT, IRMD, BVS, and TNDM

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BVS Bioventus	$13.30 -3.7%	$13.65	$6.47 ▼ $15.89	$1.16B	0.64	415,457 shs	332,985 shs
CLPT ClearPoint Neuro	$9.07 -5.9%	$13.59	$8.27 ▼ $28.10	$294.06M	1.29	796,425 shs	965,013 shs
IRMD iRadimed	$88.27 -1.2%	$86.09	$73.02 ▼ $107.90	$1.14B	0.91	132,217 shs	78,800 shs
TNDM Tandem Diabetes Care	$16.24 -1.7%	$18.96	$12.26 ▼ $29.65	$1.15B	1.66	2.34 million shs	1.63 million shs

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BVS Bioventus	+2.30%	+8.83%	+6.23%	+14.51%	+99.28%
CLPT ClearPoint Neuro	+4.33%	-8.10%	-26.69%	-36.37%	-61.18%
IRMD iRadimed	-0.51%	+4.06%	+8.45%	-7.89%	+22.17%
TNDM Tandem Diabetes Care	+3.19%	+5.36%	+1.47%	-3.28%	+12.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BVS Bioventus	$13.30 -3.7%	$13.65	$6.47 ▼ $15.89	$1.16B	0.64	415,457 shs	332,985 shs
CLPT ClearPoint Neuro	$9.07 -5.9%	$13.59	$8.27 ▼ $28.10	$294.06M	1.29	796,425 shs	965,013 shs
IRMD iRadimed	$88.27 -1.2%	$86.09	$73.02 ▼ $107.90	$1.14B	0.91	132,217 shs	78,800 shs
TNDM Tandem Diabetes Care	$16.24 -1.7%	$18.96	$12.26 ▼ $29.65	$1.15B	1.66	2.34 million shs	1.63 million shs

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BVS Bioventus	+2.30%	+8.83%	+6.23%	+14.51%	+99.28%
CLPT ClearPoint Neuro	+4.33%	-8.10%	-26.69%	-36.37%	-61.18%
IRMD iRadimed	-0.51%	+4.06%	+8.45%	-7.89%	+22.17%
TNDM Tandem Diabetes Care	+3.19%	+5.36%	+1.47%	-3.28%	+12.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BVS Bioventus	3.00	Buy	$16.80	26.32% Upside
CLPT ClearPoint Neuro	2.33	Hold	$25.67	182.98% Upside
IRMD iRadimed	2.67	Moderate Buy	$120.00	35.95% Upside
TNDM Tandem Diabetes Care	2.43	Hold	$27.08	66.74% Upside

Current Analyst Ratings Breakdown

Latest CLPT, IRMD, BVS, and TNDM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/15/2026	CLPT ClearPoint Neuro	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
10/13/2026	TNDM Tandem Diabetes Care	Mizuho Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$18.00
10/8/2026	BVS Bioventus	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold (C+) ➝ Buy (B-)
10/7/2026	TNDM Tandem Diabetes Care	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold
10/6/2026	TNDM Tandem Diabetes Care	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Overweight ➝ Positive	$18.00
10/2/2026	IRMD iRadimed	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Buy (B-) ➝ Hold (C+)
9/30/2026	TNDM Tandem Diabetes Care	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Neutral	$24.00 ➝ $20.00
9/24/2026	TNDM Tandem Diabetes Care	Truist Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$31.00 ➝ $28.00
9/22/2026	IRMD iRadimed	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Hold
9/9/2026	IRMD iRadimed	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold (C+) ➝ Buy (B-)
9/8/2026	TNDM Tandem Diabetes Care	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (E+)

(Data available from 10/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BVS Bioventus	$568.09M	1.97	$1.23 per share	10.83	$2.76 per share	4.82
CLPT ClearPoint Neuro	$36.97M	7.48	N/A	N/A	$0.99 per share	9.16
IRMD iRadimed	$83.81M	13.47	$1.84 per share	48.08	$7.44 per share	11.86
TNDM Tandem Diabetes Care	$1.01B	1.11	N/A	N/A	$2.29 per share	7.09

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BVS Bioventus	$22.73M	$0.77	18.17	14.94	1.76	9.36%	28.08%	9.82%	N/A
CLPT ClearPoint Neuro	-$25.54M	-$1.18	N/A	N/A	N/A	-81.76%	-188.09%	-40.88%	10/28/2026 (Estimated)
IRMD iRadimed	$22.48M	$1.79	49.93	N/A	N/A	26.70%	23.45%	20.36%	11/2/2026 (Estimated)
TNDM Tandem Diabetes Care	-$204.71M	-$0.93	N/A	180.44	N/A	-6.08%	-45.97%	-6.23%	11/5/2026 (Estimated)

Latest CLPT, IRMD, BVS, and TNDM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/5/2026	Q3 2026	TNDM Tandem Diabetes Care	-$0.2451	N/A	N/A	N/A	$265.84 million	N/A
11/2/2026	Q3 2026	IRMD iRadimed	$0.55	N/A	N/A	N/A	$23.47 million	N/A
10/28/2026	Q3 2026	CLPT ClearPoint Neuro	-$0.27	N/A	N/A	N/A	$12.30 million	N/A
8/6/2026	Q2 2026	TNDM Tandem Diabetes Care	-$0.3207	-$0.31	+$0.0107	-$0.31	$254.99 million	$254.56 million
8/5/2026	Q2 2026	BVS Bioventus	$0.22	$0.22	N/A	$0.47	N/A	$153.21 million
8/3/2026	Q2 2026	CLPT ClearPoint Neuro	-$0.2867	-$0.38	-$0.0933	-$0.38	$12.73 million	$10.88 million
7/31/2026	Q2 2026	IRMD iRadimed	$0.44	$0.46	+$0.02	$0.41	$20.35 million	$20.47 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BVS Bioventus	N/A	N/A	N/A	N/A	N/A
CLPT ClearPoint Neuro	N/A	N/A	N/A	N/A	N/A
IRMD iRadimed	$0.80	0.91%	N/A	44.69%	1 Years
TNDM Tandem Diabetes Care	N/A	N/A	N/A	N/A	N/A

Latest CLPT, IRMD, BVS, and TNDM Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/30/2026	IRMD iRadimed	quarterly	$0.20	0.92%	8/14/2026	8/14/2026	8/28/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BVS Bioventus	0.83	1.69	1.17
CLPT ClearPoint Neuro	4.66	4.74	3.89
IRMD iRadimed	N/A	9.46	8.13
TNDM Tandem Diabetes Care	4.62	3.18	2.65

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BVS Bioventus	62.94%
CLPT ClearPoint Neuro	30.08%
IRMD iRadimed	92.34%
TNDM Tandem Diabetes Care	N/A

Insider Ownership

Company	Insider Ownership
BVS Bioventus	33.50%
CLPT ClearPoint Neuro	6.94%
IRMD iRadimed	34.60%
TNDM Tandem Diabetes Care	2.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BVS Bioventus	950	84.09 million	55.92 million	N/A
CLPT ClearPoint Neuro	172	30.50 million	28.39 million	Optionable
IRMD iRadimed	166	12.79 million	8.36 million	Optionable
TNDM Tandem Diabetes Care	2,500	69.58 million	68.12 million	Optionable

CLPT, IRMD, BVS, and TNDM Headlines

Recent News About These Companies

Tandem Diabetes Care (NASDAQ:TNDM) Stock Jumps 4% - Here's Why

October 16 at 1:59 PM | marketbeat.com

Tandem Diabetes Care (NASDAQ:TNDM) Sees Large Volume Increase - Should You Buy?

October 15 at 11:59 AM | marketbeat.com

Tandem Diabetes Care (NASDAQ:TNDM) Stock Bought by Rep. Gilbert Ray Cisneros, Jr.

October 14 at 2:00 AM | marketbeat.com

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Stock Now Rated "Hold" by Wall Street Brokerages

October 13 at 2:28 AM | americanbankingnews.com

Tandem Diabetes Care, Inc. (TNDM) - What Are Researchers Thinking About This Stock?

October 13 at 2:28 AM | marketbeat.com

Barclays Keeps Their Hold Rating on Tandem Diabetes Care (TNDM)

October 12, 2026 | theglobeandmail.com

Is it the Right Time to Hold TNDM Stock in Your Portfolio?

October 9, 2026 | zacks.com

Tandem Diabetes Care (NASDAQ:TNDM) Stock Rating Upgraded by Barclays

October 8, 2026 | americanbankingnews.com

Tandem Diabetes Care (NASDAQ:TNDM) Upgraded at Barclays

October 8, 2026 | marketbeat.com

Barclays Starts Tandem Diabetes Care (TNDM) at Equalweight

October 7, 2026 | streetinsider.com

Barclays initiates coverage of Tandem Diabetes Care at equal-weight

October 7, 2026 | msn.com

Tandem Diabetes Care stock gains 2.36 percent before Q3 results

October 5, 2026 | ad-hoc-news.deA

Tandem Diabetes Care (TNDM) Receives a Buy from RBC Capital

October 5, 2026 | theglobeandmail.com

Tandem Diabetes Care to Announce Third Quarter 2026 Financial Results on November 5, 2026

October 1, 2026 | finance.yahoo.com

Tandem Diabetes Care (TNDM) Is Up 7.2% After International Launch Of Mobi Insulin Pump System

October 1, 2026 | finance.yahoo.com

Citigroup Issues Pessimistic Forecast for Tandem Diabetes Care (NASDAQ:TNDM) Stock Price

September 30, 2026 | marketbeat.com

Tandem Diabetes Expands Insulin Delivery System to 12 New Countries

September 28, 2026 | finance.yahoo.com

Tandem Diabetes Care, Inc. Announces Tandem Mobi Automated Insulin Delivery System Is Now Available in Twelve International Markets

September 28, 2026 | marketscreener.comM

Tandem Diabetes expands Mobi insulin system overseas

September 28, 2026 | grafa.comG

Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets

September 28, 2026 | businesswire.com

Tandem Diabetes Care(TNDM)获机构维持买入评级，目标价下调至28美元

September 26, 2026 | eeo.com.cnE

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLPT, IRMD, BVS, and TNDM Company Descriptions

Bioventus NASDAQ:BVS

$13.30 -0.51 (-3.69%)

Closing price 04:00 PM Eastern

Extended Trading

$13.29 -0.01 (-0.08%)

As of 07:40 PM Eastern

Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions include bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies comprise an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

ClearPoint Neuro NASDAQ:CLPT

$9.07 -0.57 (-5.91%)

Closing price 04:00 PM Eastern

Extended Trading

$9.11 +0.04 (+0.43%)

As of 07:47 PM Eastern

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

iRadimed NASDAQ:IRMD

$88.27 -1.10 (-1.23%)

Closing price 04:00 PM Eastern

Extended Trading

$88.31 +0.04 (+0.05%)

As of 07:59 PM Eastern

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

Tandem Diabetes Care NASDAQ:TNDM

$16.24 -0.28 (-1.69%)

Closing price 04:00 PM Eastern

Extended Trading

$16.23 -0.01 (-0.08%)

As of 07:55 PM Eastern

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CLPT, IRMD, BVS, and TNDM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CLPT, IRMD, BVS, and TNDM Earnings

Compare Dividends

Latest CLPT, IRMD, BVS, and TNDM Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CLPT, IRMD, BVS, and TNDM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLPT, IRMD, BVS, and TNDM Company Descriptions

Bioventus NASDAQ:BVS

ClearPoint Neuro NASDAQ:CLPT

iRadimed NASDAQ:IRMD

Tandem Diabetes Care NASDAQ:TNDM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CLPT, IRMD, BVS, and TNDM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CLPT, IRMD, BVS, and TNDM Earnings

Compare Dividends

Latest CLPT, IRMD, BVS, and TNDM Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CLPT, IRMD, BVS, and TNDM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLPT, IRMD, BVS, and TNDM Company Descriptions

Bioventus NASDAQ:BVS

ClearPoint Neuro NASDAQ:CLPT

iRadimed NASDAQ:IRMD

Tandem Diabetes Care NASDAQ:TNDM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools